The Q in the Quality Adjusted Life Years (QALY): Exploring New Methods
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Mar 10, 2010
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
This study explores new methodology regarding the measurement of health state utilities. A new pharmaceutical is nowadays only reimbursed if there is evidence of cost-effectiveness. This can be determined by different types of economic evaluations, of which cost-utility analysis (CUA) is preferred in most guidelines. In CUA the health outcome of a technology is measured in quality adjusted life years (QALY). Utilities to calculate QALYs should be based on decisions under uncertainty (decision utilities). However, the health care literature describes several problems that lead to bias in the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnose on one of the diseases under investigation
- • 18 years or older
- Exclusion Criteria:
- • not being able to read in Dutch
- • not able to handle the ESM device because of impaired motor skills
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hoensbroek, Limburg, Netherlands
Maastricht, Limburg, Netherlands
Patients applied
Trial Officials
Iris Maes, MSc
Principal Investigator
Maastricht Universitair Medical Centre
Manuela Joore, PhD
Principal Investigator
Maastricht University Medical Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials